GTENWMEDIUM SIGNALFINANCIAL10-Q

GTENW updated its quarterly reporting period from Q2 to Q3 2025 while increasing total offering costs and extending its business combination deadline to May 2027.

As a SPAC that has not commenced operations, the company faces mounting time pressure to complete a business combination before its May 2027 deadline (with potential extension to August 2027). The increase in offering costs to $24.2 million suggests additional expenses related to identifying and structuring a potential deal, which is typical for SPACs in their search phase.

Comparing 2025-11-12 vs 2025-08-13View on EDGAR →
FINANCIAL ANALYSIS

The company showed modest operational improvement with operating losses declining meaningfully in the quarter, while current assets decreased by approximately 20% to $782K. Total offering costs increased slightly to $24.2 million, primarily reflecting higher other offering costs, which indicates ongoing deal-sourcing activities. The financial position remains consistent with a pre-revenue SPAC structure focused on capital preservation while pursuing acquisition targets.

FINANCIAL STATEMENT CHANGES
Operating Income
P&L
+43.8%
-$338K-$190K

Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.

Current Assets
Balance Sheet
-19.8%
$975K$782K

Current assets declined 19.8% — monitor working capital adequacy and short-term liquidity.

LANGUAGE CHANGES
NEW — 2025-11-12
PRIOR — 2025-08-13
ADDED
Interim Financial Statements n Condensed Balance Sheets as of September 30, 2025 (unaudited) and December 31, 2024 3 Unaudited Condensed Statements of Operations for the Three and Nine Months Ended September 30, 2025 and 2024 4 Unaudited Condensed Statements of Changes in Shareholders' Deficit for the Three and Nine Months Ended September 30, 2025 and 202 4 5 Unaudited Condensed Statements of Cash Flows for the Nine Months Ended September 30, 2025 and 2024 7 Notes to Unaudited, Interim, Condensed Financial Statements 8 Item 2.
As of September 30, 2025, the Company had not commenced any operations.
Each Unit consists of one Class A ordinary share of the Company, par value $ 0.0001 per share (the Class A Ordinary Shares ), and one-fourth of one warrant of the Company (each, a Warrant ), with each whole Warrant entitling the holder thereof to purchase one Class A Ordinary Share for $ 11.50 per share.
Offering costs amounted to $ 24,243,141 , consisting of $ 250,000 of cash underwriting fee, $ 10,764,000 of deferred underwriting fee, $ 10,764,000 of a deferred advisory fee, and $ 2,465,141 of other offering costs.
The Company has until until May 4, 2027 (or August 4, 2027 if the Company has executed a definitive agreement for an initial Business Combination by May 4, 2027) or until such earlier liquidation date as the Company s board of directors may approve, to consummate the Company s initial business combination.
+7 more — sign up free →
REMOVED
Interim Financial Statements Condensed Balance Sheets as of June 30, 2025 (unaudited) and December 31, 2024 3 Unaudited Condensed Statements of Operations for the Three and Six Months Ended June 30, 2025 and 2024 4 Unaudited Condensed Statements of Changes in Shareholders' Deficit for the Three and Six Months Ended June 30, 2025 and 202 4 5 Unaudited Condensed Statements of Cash Flows for the Six Months Ended June 30, 2025 and 2024 6 Notes to Unaudited, Interim, Condensed Financial Statements 7 Item 2.
As of June 30, 2025, the Company had not commenced any operations.
Each Unit consists of one Class A ordinary share of the Company, par value $ 0.0001 per share (the Class A Ordinary Shares ), and one-fourth of one warrant of the Company (each, a Warrant ), with each whole Warrant entitling the holder thereof to purchase one Class A Ordinary Share for $ 11.50 per share.Transaction costs amounted to $ 10,605,256 , consisting of $ 3,320,000 of cash underwriting fee, $ 6,640,000 of deferred underwriting fee, and $ 645,256 of other offering costs.
Offering costs amounted to $ 24,168,141 , consisting of $ 250,000 of cash underwriting fee, $ 10,764,000 of deferred underwriting fee, $ 10,764,000 of a deferred advisory fee, and $ 2,390,141 of other offering costs.
The Company has until the date that is 24 months from the closing of the IPO (or 27 months from the closing of the IPO if the Company has executed a definitive agreement for an initial Business Combination within 24 months from the closing of the IPO) or until such earlier liquidation date as the Company s board of directors may approve, to consummate the Company s initial business combination.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →